AVITA Medical (RCEL) Cash from Investing Activities (2019 - 2025)

AVITA Medical (RCEL) has 7 years of Cash from Investing Activities data on file, last reported at $11000.0 in Q4 2025.

• Quarterly Cash from Investing Activities fell 99.55% year-over-year to $11000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.5 million (down 66.67% YoY) and the FY2025 annual result came in at $12.5 million, down 66.67% from the prior year.
• Cash from Investing Activities advanced to $11000.0 in Q4 2025, from -$5.3 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $56.6 million in Q4 2022 to a low of -$57.3 million in Q4 2023.
• A 5-year average of $2.0 million and a median of $7.0 million in 2025 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2021 — Cash from Investing Activities slumped 16853.38% — and 2023, when it jumped 183.12%.
• Tracing RCEL's Cash from Investing Activities over 5 years: stood at -$50.2 million in 2021, then surged by 212.81% to $56.6 million in 2022, then plunged by 201.23% to -$57.3 million in 2023, then jumped by 104.31% to $2.5 million in 2024, then tumbled by 99.55% to $11000.0 in 2025.
• The last three Cash from Investing Activities figures came in at $11000.0 (Q4 2025), -$5.3 million (Q3 2025), and $7.0 million (Q2 2025), per Business Quant data.